p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus

The Journal of Pathology

Volumn 177, Issue 1, 1995, Pages 65-70

  Jeffers, Michael D ^a   Farquharson, Maura A ^a   Richmond, James A ^a   McNicol, Ann Marie ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

immunohistochemistry; leiomyosarcoma; p53; SSCP; uterus

Indexed keywords

PROTEIN P53;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERUS TUMOR;

BASE SEQUENCE; FEMALE; GENE EXPRESSION; GENES, P53; HUMAN; IMMUNOENZYME TECHNIQUES; LEIOMYOSARCOMA; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN P53; SURVIVAL RATE; UTERINE NEOPLASMS;

EID: 0029075970     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1711770111     Document Type: Article

References (25)

1. The 1993 Walter Hubert Lecture: the role of the p53 tumour suppressor gene in tumorigenesis
2. p53 mutations in human cancers
3. Mutations of p53 gene occur in diverse tumour types
4. Tumorigenesis associated with the p53 tumour suppressor gene
5. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
6. p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours
7. p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix
8. p53 abnormalities in different subtypes of human sarcomas
9. Widespread p53 overexpression in human malignant tumours. An immunohistochemical study using methacarn fixed, embedded tissue
10. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RBI gene
11. p53 protein expression in non‐neoplastic lesions and benign and malignant neoplasms of soft tissue
12. p53 expression in neoplasms of the uterine corpus
13. Observations on tumour and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53
14. p53 immunostaining suggests that uterine carcinosarcomas are monoclonal
15. Mutation and overexpression of the p53 tumour suppressor gene frequently occurs in uterine and ovarian sarcomas
16. Pure mesenchymal neoplasms of the uterine corpus
17. Patterns of immunohistochemical staining for proliferating cell nuclear antigen and p53 in benign and neoplastic human endometrium
18. Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds
19. Antigen unmasking on formalin‐fixed, paraffin embedded tissue sections
20. Immunocytochemical p53 detection by microwave oven heating of routinely formalin‐fixed paraffin sections
21. p53 in tumour pathology: can we trust immunocytochemistry?
22. p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix
23. Amplification of a gene encoding a p53 associated protein in human sarcomas
24. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas
25. Detection of p53 in primary lung tumours and nonsmall cell lung carcinoma cell lines